These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16224741)

  • 1. [The value of levetiracetam in epileptic status].
    Pastor-Milán E; González-Torres V; Vilches R
    Rev Neurol; 2005 Oct 16-31; 41(8):508-9. PubMed ID: 16224741
    [No Abstract]   [Full Text] [Related]  

  • 2. Levetiracetam for the treatment of epilepsy among adults with intellectual disabilities.
    Deb S; Kaur Saini ST
    J Intellect Disabil Res; 2007 Jul; 51(Pt 7):564-5. PubMed ID: 17537170
    [No Abstract]   [Full Text] [Related]  

  • 3. Levetiracetam efficacy in epileptic syndromes with continuous spikes and waves during slow sleep: experience in 12 cases.
    Aeby A; Poznanski N; Verheulpen D; Wetzburger C; Van Bogaert P
    Epilepsia; 2005 Dec; 46(12):1937-42. PubMed ID: 16393159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of levetiracetam in children with epilepsy younger than 2 years of age.
    Krief P; Li Kan ; Maytal J
    J Child Neurol; 2008 May; 23(5):582-4. PubMed ID: 18448575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam-induced thrombocytopenia.
    Kimland E; Höjeberg B; von Euler M
    Epilepsia; 2004 Jul; 45(7):877-8. PubMed ID: 15230717
    [No Abstract]   [Full Text] [Related]  

  • 6. [Non-convulsive epileptic status reverted with intravenous levetiracetam].
    Callén-Soto A; Pérez-Pérez S; Robles-Del Olmo B
    Rev Neurol; 2008 Nov 1-15; 47(9):501-2. PubMed ID: 18985603
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractory epilepsy.
    Lancelin F; Franchon E; Kraoul L; Garciau I; Brovedani S; Tabaouti K; Landré E; Chassoux F; Paubel P; Piketty ML
    Ther Drug Monit; 2007 Oct; 29(5):576-83. PubMed ID: 17898647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of levetiracetam treatment in an epileptic patient with SLE.
    Siniscalchi A; Mancuso F; Gallelli L; Ferreri GI; Giovambattista DS
    Ann Pharmacother; 2005; 39(7-8):1367. PubMed ID: 15956229
    [No Abstract]   [Full Text] [Related]  

  • 9. The risk of paradoxical levetiracetam effect is increased in mentally retarded patients.
    Szucs A; Clemens Z; Jakus R; Rásonyi G; Fabó D; Holló A; Barcs G; Kelemen A; Janszky J
    Epilepsia; 2008 Jul; 49(7):1174-9. PubMed ID: 18479387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid effect of levetiracetam in a case of juvenile myoclonic epilepsy.
    Belcastro V; Costa C; Galletti F; Rossi A; Tambasco N; Striano P
    Epilepsy Behav; 2009 Jan; 14(1):269-70. PubMed ID: 18804185
    [No Abstract]   [Full Text] [Related]  

  • 11. Levetiracetam in nonconvulsive status epilepticus in childhood: a case report.
    Trabacca A; Profice P; Costanza MC; Gesualdi M; De Rinaldis M
    J Child Neurol; 2007 May; 22(5):639-41. PubMed ID: 17690075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suicidal ideation in epilepsy and levetiracetam therapy.
    Mula M; Sander JW
    Epilepsy Behav; 2007 Aug; 11(1):130-2. PubMed ID: 17544331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spritam--a new formulation of levetiracetam for epilepsy.
    Med Lett Drugs Ther; 2016 Jun; 58(1497):78-9. PubMed ID: 27305068
    [No Abstract]   [Full Text] [Related]  

  • 14. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.
    Kaminski RM; Matagne A; Patsalos PN; Klitgaard H
    Epilepsia; 2009 Mar; 50(3):387-97. PubMed ID: 18627416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Termination of absence status epilepticus by low-dose intravenous levetiracetam.
    Altenmüller DM; Kühn A; Surges R; Schulze-Bonhage A
    Epilepsia; 2008 Jul; 49(7):1289-90. PubMed ID: 18638286
    [No Abstract]   [Full Text] [Related]  

  • 16. Issues in the treatment of epilepsy.
    Leppik IE
    Epilepsia; 2001; 42 Suppl 4():1-6. PubMed ID: 11564117
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical predictors in patients with refractory epilepsy exposed to levetiracetam: a single-center study.
    Peltola J; Peltola M; Auvinen A; Keränen T; Liimatainen S; Kharazmi E; Fallah M
    Acta Neurol Scand; 2008 May; 117(5):332-6. PubMed ID: 18081915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meeting the challenge of treating epilepsy.
    Chadwick D; Wolf P
    Epileptic Disord; 2003 May; 5 Suppl 1():S7-8. PubMed ID: 12915335
    [No Abstract]   [Full Text] [Related]  

  • 19. The tolerability and efficacy of levetiracetam.
    Tellez-Zenteno JF
    Can J Neurol Sci; 2010 May; 37(3):309. PubMed ID: 20481263
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of levetiracetam in infants and young children with epilepsy.
    Glauser TA; Mitchell WG; Weinstock A; Bebin M; Chen D; Coupez R; Stockis A; Lu ZS
    Epilepsia; 2007 Jun; 48(6):1117-22. PubMed ID: 17442002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.